Pharma Co. Lied About CBD License To Investors, SEC Says
The U.S. Securities and Exchange Commission is going after a pair of pharmaceutical companies that it says lied to potential investors about having exclusive rights to a method for taking CBD...To view the full article, register now.
Already a subscriber? Click here to view full article